Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Diagnostic imaging of the patients

From: Hepatic angiomyolipoma with special attention to radiologic imaging

Characteristics ( n= 4) Finding
US - a heterogeneously hyperechoic mass (yes/no) 3/1
Plain CT - a heterogeneously low density mass with low attenuation value (< −20 HU) (yes/no) 2/2
Contrast-enhanced CT - early enhancement with delayed washout (yes/no) 3/1
Not round margin, the tumor border was irregular without capsular formation (yes/no) 1/3
Intratumoral vessels (yes/no) 2/2
Homogeneous enhancement (yes/no) 2/2
T1-weighted imaging (hypo/hyper/mixed) 2/1/1
T2-weighted imaging (hypo/hyper/mixed) 0/1/3
Fat component in chemical shift imaging (yes/no) 3/1
ADC in diffusion-weighted imaging 0.91/1.21/1.80/3.66
Hypointensity in hepatobiliary phase on T1-weighted imaging (Gd-EOB-DTPA) (yes/no) 2/0
Intratumoral vessels (yes/no) 1/3
Homogeneous enhancement (yes/no) 2/2
Dynamic CT, CT angiography, or MRI early venous return (yes/no) 3/1
  1. US, ultrasonography; CT, computed tomography; MRI, magnetic resonance imaging; ADC, apparent diffusion coefficient; Gd-EOB-DTPA, gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.